Rosa M Razaboni, MD

Locations

Physician Office

14-A East 68th Street, New York, NY, 10065

212-772-0200

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Article:8

Review Article:1

Recent Artifacts

• The effect of the delay phenomenon on the vascularity of rabbit abdominal cutaneous island flaps
• The effect of the delay phenomenon on the vascularity of rabbit rectus abdominis muscles
• The use of the latissimus dorsi musculocutaneous flap following recurrence of cancer in irradiated breasts
• Ruptured jejunum following Heimlich maneuver
• Experimental cholestasis promotes the deposition of glomerular IgA immune complexes
• Preservation of tissue for transplantation and replantation
• Stereomicroscopy as a diagnostic aid in evaluating the viability of island flaps: An experimental study
• The effects of preservation on microvascular vein grafts in rats
• The microvascular technique of vein grafting in rats as a training and experimental model

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Razaboni did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.